BioReference Health, formerly known as BioReference Laboratories, and OPKO Health have agreed to pay $9.85 million to resolve alleged violations of the False Claims Act arising from BioReference’s ...

BioReference Laboratories Inc. in Elmwood Park acquired the U.S. Ariosa centralized laboratory prenatal testing business from Roche. The Harmony Prenatal Test, Ariosa’s non-invasive prenatal screening ...

The state agreed to pay BioReference Laboratories $150 million for analyzing Covid-19 diagnostic and antibody tests through July 25, according to a database of state contracts. BioReference tests the ...

The NFL uses BioReference Laboratories for its COVID-19 testing Using a private lab doesn't add to the volume of local testing NFL teams get most test results back in 24 hours The Jaguars and 31 other ...

Ariosa's non invasive prenatal screening (NIPS) test, the Harmony Prenatal Test, is one of the most widely studied tests utilized in prenatal screening. The test has been performed in over 1.5 million ...

Scarlet brings diagnostic service to patients' homes, offices and other preferred locations, delivering an on-demand, safe and convenient diagnostic experience for patients and healthcare providers ...

BioReference Laboratories Inc. in Elmwood Park entered into a COVID-19 testing agreement for players and staff, stadium employees and league staff for the 2021 Major League Baseball season. Under the ...

Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now Practice Fusion, a major provider of ...

BioReference Labs executive chairman Jon Cohen told TheStreet’s founder, Jim Cramer, that his clinical lab “will be testing all 32 teams in 30 different cities around the country” during the upcoming ...

ELMWOOD PARK, N.J.—In early July, as coronavirus surged across the U.S., one of the nation’s biggest laboratories involved in testing for Covid-19 made a wrenching decision: It would stop accepting ...